Data are baseline values except otherwise noted. 1 Sample size of the subgroup population which was effectively genotyped. 2 Change from baseline (Visit 2, the day before study treatment initiation) to endpoint (Visit 5, study treatment termination 
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Supplementary Figure 1. Functional classification of the genes from the pre-treatment at visit 2 (V2) and post-treatment at visit 5 (V5) EHT 0202 signatures. A significant number of genes from both signatures are involved in, or associated with the main biological and the pathophysiological processes in Alzheimer's disease. Gene numbers are given for each category. Genes in red exhibit upregulated probe sets in improving patients while genes in green exhibit down-regulated probe sets in improving patients. Post-treatment, the signature genes that discriminate responding from declining subjects are less numerous in each category except vascular disorder (no change), and gene expression, carbohydrate and lipid metabolism functions (all three highly enriched in the post-treatment signature). Mitochondrial function, oxidative stress and calcium signaling are shown for information but were not significantly represented in the two signatures. Threshold for significance: p < 0.05 by the right-tailed Fisher's exact test.
